Other institutional investors have also recently added to or reduced their stakes in the company. Burgundy Asset Management Ltd. raised its position in shares of Walgreens Boots Alliance by 0.6% during the 3rd quarter.
Shares of Microsoft, Facebook and Google-parent Alphabet rose more than 1 percent as the technology sector recovered from a recent selloff. Over the past week, Walgreens Boots Alliance, Inc. As per Monday, August 24, the company rating was downgraded by Zacks. Andra AP fonden increased its holdings in shares of Walgreens Boots Alliance by 35.3% during the 2nd quarter. The Hallmark Capital Management Inc holds 91,791 shares with $17.27 million value, down from 93,470 last quarter. AXA lifted its position in shares of Walgreens Boots Alliance by 12.4% in the 3rd quarter.
Sinopharm Group will hold the remaining 60 per cent stock. RAD has a short ratio of 5.95 compared to a short interest of 2.99 for WBA. The shares were sold at an average price of $67.37, for a total value of $184,324.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director John Anthony Lederer purchased 20,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, October 26th. The formula for calculating the price-earnings ratio for any stock is simple: the market value per share divided by the earnings per share (EPS). Insiders own 14.80% of the company's stock. (WBA) stock price fell -16.13 percent over the past one year, while decreased -12.79 percent during the past 6 months. Walgreens Boots Alliance Inc has a 52 week low of $63.82 and a 52 week high of $88.00. Stocks with a beta above 1 tend to have bigger swings in price than the market as a whole, the opposite being the case for stocks with a beta below 1.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Wednesday, October 25th. After $1.31 actual earnings per share reported by Walgreens Boots Alliance, Inc. for the previous quarter, Wall Street now forecasts -3.82 % negative EPS growth. The company had revenue of $30.15 billion during the quarter, compared to the consensus estimate of $29.93 billion. Its sales stood at 10.50% a year on average in the period of last five years. Walgreens Boots Alliance's revenue for the quarter was up 5.3% on a year-over-year basis. analysts predict that Walgreens Boots Alliance Inc will post 5.55 earnings per share for the current fiscal year. The degree to which a PEG ratio value indicates an over or underpriced stock varies by industry and by company type; though a broad rule of thumb is that a PEG ratio below one is desirable.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Thursday, May 18th will be paid a $0.375 dividend. At the current valuation, this equates to a dividend yield of 2.28%. Walgreens Boots Alliance's dividend payout ratio is now 39.68%. (NASDAQ:WBA) is a huge mover today!
Following a public tender process, Walgreens Boots Alliance's bid met all the requirements set by the seller to acquire a 40% minority stake in GuoDa through a capital increase worth about $416 million. Cantor Fitzgerald maintained the stock with "Buy" rating in Wednesday, October 25 report. Finally, Jefferies Group LLC reissued a "buy" rating and issued a $95.00 price objective on shares of Walgreens Boots Alliance in a report on Friday, March 31st.
10 analysts rate Walgreens Boots Alliance, Inc. a Buy or Strong Buy, which is 62.5% of all the analyst ratings. Finally, Needham & Company LLC restated a "buy" rating and set a $94.00 price target on shares of Walgreens Boots Alliance in a report on Sunday, September 10th.
Among 13 analysts covering Gem Diamonds Ltd (LON:GEMD), 4 have Buy rating, 2 Sell and 7 Hold.
Taking a closer look from a technical standpoint, Walgreens Boots Alliance (WBA) presently has a 14-day Commodity Channel Index (CCI) of -51.93. If you are viewing this piece of content on another publication, it was illegally stolen and reposted in violation of United States & worldwide trademark and copyright laws. More interesting news about Walgreens Boots Alliance, Inc.
The EPS this year for Walgreens Boots Alliance, Inc., WBA is 3.78 following the EPC growth of next year of 9.29%. "It is China's leading pharmacy chain and we believe that we can positively contribute to its continued successful development with our global pharmacy expertise".
GuoDa, which operates and franchises 3,500 retail pharmacies across 70 cities in China, said the Walgreens investment would help its nationwide expansion plans. The Company's products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).